US4448591028 - Common Stock
Monday's session: gap up and gap down stock in the S&P500 index
Better-than-expected Medicare Advantage membership aids HUM's third-quarter results.
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Humana Inc.’s third-quarter profit exceeded Wall Street expectations and the company issued a more optimistic forecast, breaking with larger peers that have struggled to contain medical costs.
Evaluate the expected performance of Humana (HUM) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised...
Humana (HUM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.